EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Narcolepsy 2025 (with an Australasian perspective)

Amelia Lin iD, Brendon J Yee, Jian Eu Tai, Sheila Sivam

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Amelia Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: CIRUS Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Narcolepsy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Narcolepsy is a disorder of central hypersomnolence, which, while uncommon, can carry profound implications for affected individuals. Despite this, it remains under‐recognised within the medical community and presents frequent diagnostic and treatment challenges in the Australasian setting. Narcolepsy is subdivided into narcolepsy type 1, characterised by cataplexy and deficiency of the neuropeptide orexin, and narcolepsy type 2, a distinct entity. The latter can be further difficult to distinguish from the separate central hypersomnolence disorder idiopathic hypersomnia. Implementation of diagnostic criteria to distinguish these conditions is not always straightforward, however, with consideration of comorbidities and test conditions required to avoid misdiagnoses. Within Australia and New Zealand, narcolepsy remains relatively ill‐defined on a population level compared to other developed nations, and greater challenges exist in access to diagnostic testing and therapeutic options. Internationally, orexin receptor 2 agonists have displayed promise as oral therapy to target the neurobiological basis of narcolepsy, particularly narcolepsy type 1, with further testing underway. We discuss practical challenges and updates in narcolepsy from an Australasian perspective, with a view to improve awareness of narcolepsy in both primary and specialty medicine to support access to care for individuals with the condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NarcolepsyHumansAustralasiaAustraliaNew ZealandOrexins

Stichwörter der Autor:innen

cataplexyhypersomnolencenarcolepsyorexin

Substanzen

Orexins

Autor:innen und Institutionen

  • CIRUS Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: Amelia Lin

Zitieren

APA

Lin, A., Yee, B. J., Tai, J. E., & Sivam, S. (2025). Narcolepsy 2025 (with an Australasian perspective). Internal Medicine Journal. https://doi.org/10.1111/imj.70186

Vancouver

Lin A, Yee BJ, Tai JE, Sivam S. Narcolepsy 2025 (with an Australasian perspective). Internal Medicine Journal. 2025. doi:10.1111/imj.70186

BibTeX
@article{Lin2025,
  author = {Lin, Amelia and Yee, Brendon J and Tai, Jian Eu and Sivam, Sheila},
  title = {Narcolepsy 2025 (with an Australasian perspective)},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70186}
}
Kostenlos starten →